Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW
16,960
+200 (1.19%)
Apr 10, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
Genomic Analysis and Other Business | | | 1.60B | 28.09B | 2.84B | 1.07B | 221.22M | |
Genomic Analysis and Other Business Growth | | | -94.32% | 889.33% | 164.63% | 384.96% | -42.83% | |
Cancer Molecular Diagnosis Business | | | 1.82B | 1.78B | 2.30B | 166.02M | 60.41M | |
Cancer Molecular Diagnosis Business Growth | | | 2.45% | -22.72% | 1285.70% | 174.84% | - | |
| | | 3.42B | 29.87B | 5.14B | 1.24B | 281.63M | |
| | | -88.56% | 481.09% | 314.87% | 339.89% | -27.22% | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| | | 1.87B | 1.82B | 398.06M | 310.47M | 273.37M | |
| | | 2.90% | 357.30% | 28.21% | 13.57% | -27.98% | |
| | | - | - | 2.00B | - | - | |
| | | 14.85M | 11.16M | - | - | - | |
| | | 33.10% | - | - | - | - | |
| | | 1.53B | 28.03B | 2.74B | 928.38M | 8.26M | |
| | | -94.54% | 922.56% | 195.31% | 11138.12% | 11.94% | |
| | | 3.42B | 29.87B | 5.14B | 1.24B | 281.63M | |
| | | -88.56% | 481.09% | 314.87% | 339.89% | -27.22% | |
Source: S&P Global Market Intelligence.
